The Tendonitis Market to Exhibit Growth at a CAGR of 2.9% In The 7MM During The Study Period (2018-30), Assesses DelveInsight
The tendonitis market is expected to grow significantly owing to an increase in the targeted patient pool and novel treatment approaches by the leading companies such as R3 Stem Cell, TRB Chemedica, InGeneron, MiMedx Group, among others.
LAS VEGAS, April 14, 2022 /PRNewswire/ -- DelveInsight's Tendonitis Market Insights report includes a comprehensive understanding of current treatment practices, Tendonitis emerging drugs, market share of individual therapies, and current and forecasted market size from 2018 to 2030, segmented into 7MM (the United States, the EU5 (the United Kingdom, Italy, Spain, France, and Germany), and Japan.
Key Takeaways from the Tendonitis Market
- According to DelveInsight estimates, the United States is likely to hold the maximum Tendonitis market size which is expected to increase with a CAGR of 4.3% during the study period (2018-30).
- As per analysis, the total Tendonitis incident cases were found to be more than 11 million in the 7MM in 2020.
- Key Tendonitis companies such as TRB Chemedica, CollPlant, MiMedx Group, University of Wisconsin-Madison/GE Electric Healthcare, Seikagaku Corporation, Ono Pharmaceutical, R3 Stem Cell, University of Wisconsin-Madison, DePuy Synthes, Orthocell, InGeneron, and others are currently working to develop new drugs for Tendonitis which can be available in the Tendonitis market in the upcoming years.
- The Tendonitis therapies in the pipeline include AmnioFix (Micronized DHACM), Platelet-rich Plasma (PRP), Joyclu (Diclofenac Etalhyaluronate/SI-613),), Amniotic Fluid Tissue, Ortho-ATI, Adipose-Derived Regenerative Cells, and others.
Discover more about therapies set to grab major Tendonitis market share @ Tendonitis Market Landscape
Tendonitis Overview
Tendonitis is an inflammation of a tendon, which is a thick, flexible cord of tissue that connects muscles to bone and helps the bone or structure move. Tendonitis most frequently affects the shoulder, bicep, elbow, hand, wrist, thumb, calf, knee, or ankle. The most common types of tendonitis include Tennis elbow tendonitis, golfer's elbow tendonitis, patellar tendonitis, Achilles tendonitis, supraspinatus tendonitis, trigger finger, or trigger thumb, wrist tendonitis, peroneal tendonitis, and posterior tibial tendonitis.
Tendonitis causes inflammation, soreness, and discomfort in the tendons, ligaments, and muscles around a joint. Different types of tendonitis might strike quickly and continue for days or weeks. The discomfort is exacerbated by movement and normally improves with rest or medication. Tendonitis symptoms might reoccur in the same body part.
Tendonitis symptoms often include discomfort and are commonly characterized as a dull aching (particularly while moving the afflicted limb or joint), soreness, and minor swelling at the place where a tendon joins to a bone.
Tendonitis can be diagnosed if there is discomfort at a specific place in the tendon. If the patient does not react to therapy, the doctor may order various testing. An x-ray can reveal calcium deposits surrounding the tendon, which can aid in Tendonitis diagnosis. Other imaging procedures for Tendonitis diagnosis, such as ultrasound or MRI, may indicate tendon sheath edema.
Tendonitis Epidemiology Segmentation
As per DelveInsight, the total Tendonitis incident cases were found to be more than 11 million in the 7MM in 2020.
The total Tendonitis treated cases was more than 5 million in the 7MM in 2020.
The Tendonitis Market Report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
- Total Incident Cases of Tendonitis
- Total Gender-specific Cases of Tendonitis
- Total Region-specific Cases of Tendonitis
- Total Treated Cases of Tendonitis
Download the report to understand which factors are driving Tendonitis epidemiology trends @ Tendonitis Epidemiological Insights
Tendonitis Treatment Market
Tendonitis may go away over time. If this is not the case, the doctor will offer therapies to minimize pain and inflammation while preserving mobility. Severe symptoms of tendonitis may necessitate the services of a rheumatologist, orthopedic surgeon, or physical therapist. Most tendonitis symptoms, when properly treated, do not result in lasting joint damage or disability. RICE (Rest, Ice, Compression, Elevation) therapy; physical or occupational therapy; splints, braces, or slings these assistive Tendonitis devices allow the affected area to rest until the pain subsides; over-the-counter (OTC) and prescription medications; and corticosteroids injections are all Tendonitis treatment options.
Treatment for Tendonitis aims to alleviate pain and minimize inflammation. Failure to rest will almost certainly prolong the symptoms. If the problem is in a hip, leg, or foot, they may need to refrain from strenuous weight-bearing activities for a brief period of time. This allows the irritation to subside. Ice may aid in the reduction of inflammation and discomfort. Once or twice a day, freeze the affected region for 10–15 minutes. If the pain persists, patients may require nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, or naproxen. Topical NSAIDs are now available and may relieve pain and inflammation without causing stomach problems. In addition, acetaminophen (Tylenol) can help with pain relief.
Discover more about therapy set to grab substantial Tendonitis market share @ Tendonitis Treatment
Tendonitis Pipeline Therapies and Key Players
- AmnioFix (Micronized DHACM): MiMedx Group
- Platelet-rich Plasma (PRP): University of Wisconsin-Madison/GE Electric Healthcare
- Joyclu (Diclofenac Etalhyaluronate/ SI-613): Seikagaku Corporation/Ono Pharmaceutical
- Amniotic Fluid Tissue: R3 Stem Cell
- Platelet-rich Plasma (PRP): University of Wisconsin-Madison/ DePuy Synthes
- Ortho-ATI: Orthocell
- Adipose-Derived Regenerative Cells: InGeneron
To know about more new drugs for Tendonitis treatment available in the tendonitis market visit @ Best Anti-inflammatory Drugs for Tendonitis Treatment
Tendinopathy is becoming more common in the developed world as a result of greater engagement in leisure activities and an older population. As a result, the Tendonitis market is anticipated to increase significantly owing to an increase in the targeted patient pool. Moreover, the anticipated launch of upcoming targeted therapy options and novel treatment approaches by leading companies such as, TRB Chemedica, CollPlant, MiMedx Group, among others for tendonitis treatment would provide hope to patients and have a beneficial impact on the Tendonitis market.
Nevertheless, there are certain limitations associated with the current Tendonitis treatment which are impeding the Tendonitis market growth. The lack of awareness of the biology and clinical importance of the condition may limit the right diagnosis, perhaps leading to a delayed diagnosis and misdiagnosis, the greatest problem of tendonitis treatment and thus limiting the growth of the Tendonitis market. Furthermore, one of the key causes of poor patient care is a breakdown in communication between doctors and patients. It may stifle the expansion of the Tendonitis market and access to treatments. In addition, despite several clinical advancements in the treatment for Tendonitis, there is still an unmet need for effective therapeutic options to supplement intrinsic and surgical healing. These above-mentioned factors are acting as a barrier to Tendonitis market growth.
Scope of the Tendonitis Market Report
- Study Period: 2018-2030
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Tendonitis Companies: TRB Chemedica, CollPlant, MiMedx Group, University of Wisconsin-Madison/GE Electric Healthcare, Seikagaku Corporation, Ono Pharmaceutical, Novartis, R3 Stem Cell, University of Wisconsin-Madison, DePuy Synthes, Orthocell, InGeneron, and others
- Key Pipeline Therapies: AmnioFix (Micronized DHACM), Platelet-rich Plasma (PRP), Joyclu (Diclofenac Etalhyaluronate/SI-613), Cosentyx (Secukinumab/AIN457), Amniotic Fluid Tissue, Ortho-ATI, Adipose-Derived Regenerative Cells, and others
- Therapeutic Assessment: Tendonitis current marketed and emerging therapies
- Tendonitis Market Dynamics: Tendonitis market drivers and barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
- Unmet Needs, KOL's views, Analyst's views, Tendonitis Market Access and Reimbursement
Discover more about the future Tendonitis market share of treatment therapies @ Drugs for Tendonitis Treatment
Table of Contents
1. | Tendonitis Market Key Insights |
2. | Tendonitis Market Report Introduction |
3. | Tendonitis Market Overview at a Glance |
4. | Tendonitis Market Executive Summary |
5. | Disease Background and Overview |
6. | Treatment and Management |
7. | Epidemiology and Patient Population |
8. | Patient Journey |
9. | Tendonitis Marketed Therapies |
10. | Tendonitis Emerging Drugs |
11. | 7 Major Tendonitis Market Analysis |
12. | Tendonitis Market Outlook |
13. | Potential of Current and Emerging Therapies |
14. | KOL Views |
15. | Tendonitis Market Drivers |
16 | Tendonitis Market Barriers |
17. | Unmet Needs |
18. | SWOT Analysis |
19. | Appendix |
20. | DelveInsight Capabilities |
21. | Disclaimer |
22. | About DelveInsight |
Get in touch with our Business executive @ Healthcare Due Diligence Services
Related Reports
Tendonitis Epidemiology Forecast to 2032 report delivers an in-depth understanding of the disease, historical, and forecasted Tendonitis epidemiology in the 7MM.
Tendonitis Pipeline Insight, 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key Tendonitis companies involved such as Dobecure, Causeway Therapeutics, among others.
Tendinopathy Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Tendinopathy companies such as TRB Chemedica, CollPlant, MiMedx Group, among others.
Tendinopathy Epidemiology Forecast to 2032 report delivers an in-depth understanding of the disease, historical, and forecasted Tendonitis epidemiology in the 7MM.
Tendinopathy Pipeline Insight, 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key Tendinopathy companies involved such as Orthocell, InGeneron, Causeway Therapeutics, among others.
Other Trending Reports
Systemic Inflammatory Response Syndrome Market
Systemic Inflammatory Response Syndrome Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Systemic Inflammatory Response Syndrome companies such as Cidera Therapeutics, ContraFect, Scynexis, among others.
Primary Ciliary Dyskinesia Market
Primary Ciliary Dyskinesia Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Primary Ciliary Dyskinesia companies such as Parion Sciences, ReCode Therapeutics, Translate Bio, among others.
Exanthema Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Exanthema companies in the domain.
Motor Neuron Disease Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Motor Neuron Disease companies in the domain.
Paraganglioma Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Paraganglioma companies in the domain.
Latest Healthcare Blogs
Treatment-resistant Hypertension Market
Top Drugs Losing Patent in 2022
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Connect With Us at LinkedIn | Facebook | Twitter
Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com
Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
Share this article